Molecular Mechanisms of MmpL3 Function and Inhibition

被引:8
作者
Williams, John T. [1 ]
Abramovitch, Robert B. [1 ,2 ]
机构
[1] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Microbiol & Mol Genet, 567 Wilson Rd, E Lansing, MI 48824 USA
关键词
Mycobacterium tuberculosis; MmpL3; phenotypic drug discovery; FATTY-ACID SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS ENCODES; CYCLOPROPANATED MYCOLIC ACIDS; CELL-WALL; CRYSTAL-STRUCTURE; TUBERCLE-BACILLI; GENE-EXPRESSION; OUTER-MEMBRANE; IN-VITRO; BIOCHEMICAL-CHARACTERIZATION;
D O I
10.1089/mdr.2021.0424
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mycobacteria species include a large number of pathogenic organisms such as Mycobacterium tuberculosis, Mycobacterium leprae, and various non-tuberculous mycobacteria. Mycobacterial membrane protein large 3 (MmpL3) is an essential mycolic acid and lipid transporter required for growth and cell viability. In the last decade, numerous studies have characterized MmpL3 with respect to protein function, localization, regulation, and substrate/inhibitor interactions. This review summarizes new findings in the field and seeks to assess future areas of research in our rapidly expanding understanding of MmpL3 as a drug target. An atlas of known MmpL3 mutations that provide resistance to inhibitors is presented, which maps amino acid substitutions to specific structural domains of MmpL3. In addition, chemical features of distinct classes of Mmpl3 inhibitors are compared to provide insights into shared and unique features of varied MmpL3 inhibitors.
引用
收藏
页码:190 / 212
页数:23
相关论文
共 213 条
  • [1] Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
    Abrahams, Katherine A.
    Cox, Jonathan A. G.
    Spivey, Vickey L.
    Loman, Nicholas J.
    Pallen, Mark J.
    Constantinidou, Chrystala
    Fernandez, Raquel
    Alemparte, Carlos
    Remuinan, Modesto J.
    Barros, David
    Ballell, Lluis
    Besra, Gurdyal S.
    [J]. PLOS ONE, 2012, 7 (12):
  • [2] Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: An emergent therapeutic target
    Adams, Oliver
    Deme, Justin C.
    Parker, Joanne L.
    Fowler, Philip W.
    Lea, Susan M.
    Newstead, Simon
    [J]. STRUCTURE, 2021, 29 (10) : 1182 - +
  • [3] Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis
    Alangaden, GJ
    Kreiswirth, BN
    Aouad, A
    Khetarpal, M
    Igno, FR
    Moghazeh, SL
    Manavathu, EK
    Lerner, SA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1295 - 1297
  • [4] Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility
    Aldridge, Bree B.
    Fernandez-Suarez, Marta
    Heller, Danielle
    Ambravaneswaran, Vijay
    Irimia, Daniel
    Toner, Mehmet
    Fortune, Sarah M.
    [J]. SCIENCE, 2012, 335 (6064) : 100 - 104
  • [5] Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL):: The effect of isoniazid on gene expression in Mycobacterium tuberculosis
    Alland, D
    Kramnik, I
    Weisbrod, TR
    Otsubo, L
    Cerny, R
    Miller, LP
    Jacobs, WR
    Bloom, BR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) : 13227 - 13232
  • [6] Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition
    Alland, D
    Steyn, AJ
    Weisbrod, T
    Aldrich, K
    Jacobs, WR
    [J]. JOURNAL OF BACTERIOLOGY, 2000, 182 (07) : 1802 - 1811
  • [7] A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
    Andries, K
    Verhasselt, P
    Guillemont, J
    Göhlmann, HWH
    Neefs, JM
    Winkler, H
    Van Gestel, J
    Timmerman, P
    Zhu, M
    Lee, E
    Williams, P
    de Chaffoy, D
    Huitric, E
    Hoffner, S
    Cambau, E
    Truffot-Pernot, C
    Lounis, N
    Jarlier, V
    [J]. SCIENCE, 2005, 307 (5707) : 223 - 227
  • [8] Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv:: Effect on growth in culture and in macrophages
    Armitige, LY
    Jagannath, C
    Wanger, AR
    Norris, SJ
    [J]. INFECTION AND IMMUNITY, 2000, 68 (02) : 767 - 778
  • [9] The Three Mycobacterium tuberculosis Antigen 85 Isoforms Have Unique Substrates and Activities Determined by Non-active Site Regions
    Backus, Keriann M.
    Dolan, Michael A.
    Barry, Conor S.
    Joe, Maju
    McPhie, Peter
    Boshoff, Helena I. M.
    Lowary, Todd L.
    Davis, Benjamin G.
    Barry, Clifton E., III
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (36) : 25041 - 25053
  • [10] The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance
    Banerjee, A
    Sugantino, M
    Sacchettini, JC
    Jacobs, WR
    [J]. MICROBIOLOGY-SGM, 1998, 144 : 2697 - 2704